Regulatory UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention PharmaTimesClesrovimab is first monoclonal antibody offering a single fixed dose for infantsInfectious DiseaseRead full story pharminent April 27, 2026 (Last updated: April 27, 2026) PharmaTimes Clesrovimab is first monoclonal antibody offering a single fixed dose for infants Infectious Disease Read full story Post navigation Previous: Sun Pharma to acquire Organon for $11.75bnNext: UK biotech could be bound for recovery, BIA report reveals Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026